Skip to main content
Explore URMC
menu
URMC / Research / Clinical Trials / Study Details

UBMT17044 / HBO-UBC / Omar Aljitawi

Research Question:
Will the use of hyperbaric oxygen (HBO) therapy prior to the UCB transplant improve the stem cell homing, and subsequently, the engraftment?

Basic Study Information

Purpose:
The UCB transplant is a type of stem cell transplant used to treat cancer of the blood or lymph glands. The UCB transplant has advantages over other types of transplants such as ease of obtaining the umbilical cord blood, absence of donor risks, reduced risks of contagious infections, and the availability for immediate use. The UCB transplant is also associated with a lower incidence of graft versus host disease, or GvHD (in GvHD, the transplanted graft attacks the recipient organs).

Location: University of Rochester Medical Center
Study Reference #: UBMT17044

Lead Researcher (Principal Investigator)

Lead Researcher:  Omar Aljitawi

Study Contact Information

Study Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Email: tina_bowdish@urmc.rochester.edu

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search